125742 S1 M5 5351 bnt162 01 interim3 sponsor personnel list

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

1

Download PDF ↗ Live URL (may be dead)

Document text

BioNTech RNA 
Pharmaceuticals GmbH  
Confidential  Interim Clinical Study  Report  
BNT162 -01 Page 1 of 1 
Version: 2.0 
Date: 26 Nov 2020  
 
16.1. 13 List of sponsor personnel who materially affected the trial conduct  
The following table presents a list of sponsor personnel who materially affected the trial conduct. The full list of all involved sponsor 
personnel is maintained in the trial master file ( TMF). 
 
Name  Role  
Özlem Türeci , MD  Chief Medical Officer ( Spons or’s medically qualified person ) b 
Svetlana Shpyro , MD  Medical Expert  
Dr. Stefan Liebscher  Biostatistician (External BioNTech Consultant)  
Sean Murphy  Biostatistician (External BioNTech Consultant)  
Dr. Christopher Marshallsay  Head Scientific -Medical Writing  a 
Dr. Frans van Huizen  Senior Scientific / Medical Writer  
Dr. David Langer  Clinical Study Manager  
Dr. Stefanie Bolte  Clinical Study Manager  
Martin Bexon , MD  Medical Monitor  (External BioNTech Consultant)  
Amélie Caneparo  Pharmacovigilance Manager  
Claudia Müller  Clinical Data Manager (External BioNTech Consultant)  
Dr. Tania Palanche  Senior Clinical Data Manager  
a) Document owner fulfills the requirements of the author according to ICH E3.  
b) Corresponds to the medical officer defined in ICH E3.  
 
090177e195a37562\Approved\Approved On: 28-Nov-2020 02:43 (GMT) 
Page 1
FDA-CBER-2021-5683-0049413